🔎 Trials Near Me

Home › Triple-Negative Breast Cancer › Florida › Sarasota

Triple-Negative Breast Cancer clinical trials in Sarasota, FL

8 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Sarasota (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of AVZO-021 in Patients With Advanced Solid Tumors

RecruitingPhase 1/2
  • Avenzo Therapeutics Recruiting Site, Sarasota
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

RecruitingPhase 1
  • SCRI Florida Cancer Specialists - Sarasota, Sarasota
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07029399

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

RecruitingPhase 1
  • Florida Cancer Specialists - Sarasota, Sarasota
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT06150664

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

RecruitingPhase 1/2
  • Florida Cancer Specialists, Sarasota
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

RecruitingPhase 1
  • Florida Cancer Specialists - Sarasota, Sarasota
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT07046923

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

RecruitingPhase 1
  • Florida Cancer Specialists, Sarasota
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07503808

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

RecruitingPhase 1
  • Dren Investigational Site, Sarasota
Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT06999187

Triple-Negative Breast Cancer trials in other cities

Other studies in Sarasota

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.